Equine Infectious Anemia: 3 Clinical Phases And Prevention

Equine Infectious Anemia (EIA), often called swamp fever, is a viral disease that affects horses, donkeys, mules, and zebras worldwide. Caused by a lentivirus, it leads to lifelong infection with no cure or vaccine available. Horses may show severe symptoms or remain asymptomatic carriers, posing significant risks to herds through transmission.

The Viral Culprit Behind EIA

The pathogen responsible is Lentivirus equinfane, an RNA virus from the Retroviridae family. This virus integrates into the host’s DNA, evading complete clearance by the immune system. Infection disrupts macrophage function, triggering excessive proinflammatory cytokines like TNF-alpha, IL-1, IL-6, and TGF-beta. These mediators cause fever via prostaglandin pathways, suppress blood cell production leading to thrombocytopenia and anemia, and promote immune complex damage resulting in edema and organ inflammation.

Viral strains vary in virulence, influencing disease severity. Regional isolates can differ genetically, impacting diagnostic test sensitivity.

How EIA Spreads Among Equids

Transmission occurs primarily through blood-feeding insects like horseflies and deerflies, which mechanically transfer virus-laden blood. Direct contact with infected fluids, such as during breeding or shared equipment, also spreads it. Critically, iatrogenic spread—via contaminated needles, syringes, dental tools, or surgical instruments—is a major concern, with the virus surviving up to 96 hours on needles.

• Mechanical vectors: Tabinid flies (horseflies, deerflies)
• Iatrogenic routes: Reused needles, blood transfusions, shared tack
• Other: Rarely, vertical transmission from mare to foal

Horse owners must prioritize single-use equipment and insect control to curb outbreaks.

Recognizing EIA Clinical Phases

EIA progresses variably after a 15-45 day incubation. Most cases follow three phases: acute, subacute/chronic recurrent, and inapparent carrier.

Acute Phase

Lasting 1-3 days, this explosive onset features high fever (up to 106°F), depression, inappetence, and rapid thrombocytopenia. Horses may collapse or die, with jaundice, epistaxis, or bloody feces in severe cases. Signs are often missed due to brevity.

Subacute and Chronic Recurrent Phase

Following acute illness, recurrent fever episodes (1-5 days) recur every 1-3 months, triggered by stress, exercise, or immunosuppression. Symptoms include weight loss, ventral edema, muscle wasting, anemia, petechiae on mucous membranes, and weakness. Ophthalmic issues like choroidal depigmentation may appear.

Inapparent Carrier State

Over 70% of infected horses become lifelong asymptomatic carriers after immune adaptation. They shed virus intermittently, especially under stress, remaining a hidden threat.

Post-Mortem Findings in EIA Cases

Necropsies reveal splenomegaly, hepatomegaly, lymph node enlargement, dependent edema, and petechial hemorrhages on serosal surfaces, kidneys, and spleen. Chronic cases show emaciation, pale mucosae, thrombosis, and glomerular changes. Asymptomatic carriers often lack gross lesions.

Accurate Diagnosis of EIA

Diagnosis relies on serology detecting antibodies, as viremia wanes post-acute phase. The agar gel immunodiffusion (AGID or Coggins test) is the gold standard, confirmed by competitive ELISA if needed. RT-PCR detects viral RNA in acute cases or carriers.

Testing is mandatory for travel, shows, sales, and breeding. False negatives are rare post-45 days; foals from positive mares need dual testing.

• Coggins Test (AGID): Official, detects antibodies in 1-2 weeks
• ELISA: Faster screening, high sensitivity
• PCR: Confirms active infection

No Cure: Management and Control Strategies

No antiviral therapy or vaccine exists. Positive horses are lifelong carriers requiring euthanasia or permanent quarantine (200+ yards from equids) with strict insect barriers.

Supportive care for acute cases includes fluids, anti-inflammatories, and blood transfusions, but survival doesn’t eliminate carrier status.

Prevention: The Best Defense Against EIA

Regular Coggins testing (annually or before events) identifies carriers. Biosecurity is paramount:

• Use disposable needles/syringes
• Disinfect equipment with 2% glutaraldehyde
• Control flies with screens, repellents, pour-ons
• Quarantine new arrivals for 3 weeks
• Avoid communal water troughs

Many U.S. states enforce EIA regulations via departments like Nebraska’s NDA or Wisconsin’s DATCP.

Frequently Asked Questions (FAQs)

What is the Coggins test?

The Coggins test is an AGID serology test confirming EIA antibodies, required for interstate horse movement.

Can EIA be transmitted to humans?

No, EIA is equine-specific and not zoonotic.

How long does the virus survive outside the horse?

Up to 96 hours on contaminated needles; sensitive to disinfectants.

Is there a vaccine for EIA?

No approved vaccine exists globally.

What should I do if my horse tests positive?

Contact your vet and state vet authority for quarantine or euthanasia options.

Global Impact and Regulatory Landscape

EIA persists worldwide, with U.S. cases traced to lapses in testing. Organizations like the Equine Disease Communication Center track outbreaks. State ag departments mandate reporting and movement controls.

Horse owners play a key role in eradication efforts through vigilance and compliance.